From June 10 to July 10, Free Shipping via Airmail.
Xianling Gubao Main Function:
Xianling Gubao Capsule replenishes vital essence and tonifies the kidney, improves health and strengthens the bones.
The herbal formula can actually help to reduce:
- Listlessness and lassitude
- Soreness and weakness of the loins and knees
- Dizziness and tinnitus
- arthralgia of the middle-age and senior citizens and due to osteoprosis
- Traumatic injury
Helps the Body to Protect Itself from:
Epimedium brevicornum Maxim.,Dipsacus aspercides c. Y. Cheng et.,Psoralea corylifolia L.,Rehmannia glutinosa Libosch., Salvia miltiorrhiza Beg., Anemarrhena asphodeloides Beg.
500 mg each capsule, 30 caps each package.
Orally, Take 3 Xianling Gubao capsules with water each time. 2 times daily.
The first treatment course is 5 packets.
Keep out reach of children.
Store in a cool dry place.
Avoid use during pregnancy.
Made in China
Report about Xianling Gubao Capsule:
The Week in Review: Regenerx Wins China Patent - ChinaBio® Today
In other China biopharma news last week, Tongjitang China Medicines (NYSE: TCM) reported positive results from a two-year, western-style clinical trial of its traditional Chinese medicine for osteoporosis, Xianling Gubao (see story).
After six months of treatment, Xianling Gubao reduced bone resorption by 25% (the process of bone loss) and increased the bone density of the spine (the lumbar vertebrae L1) by up to 3.1%.
Without Xianling Gubao, the density loss in bone can be as much as 2% per year.
Tongjitang will use the data to support a request for FDA approval of Xianling Gubao, which Tongjitang believes is still three to five years in the future.
Synarc, the US-based company that specializes in radiology and biochemical biomarker clinical trials, conducted the trial from its Beijing office.
British Library Direct: Effects of Xianling Gubao capsule on bone ...
Effects of Xianling Gubao capsule on bone mineral density and cytokines in postmenopausal osteoporotic patients (Abstract)
Objective To study the effects of Xianling Gubao XLGB capsule on bone mineral density and cytokines in patients with postmenopausal osteopossis(PMO). Methods 178 PMO patients aged from 55 to 60 years were randomized in to three groups.
All of them received Leli capsules (calcium preparation) 1.0g/day. Group A, 62 patients, received XLGB capsules 1.0g, bid; group B, 66 patients, received livial 1.25 mg/day, group 50 patients received Lele capsules only. 20 women, 55-60(57.4 ± 3.54) years old, were recruited as normal controls.
Dual-energy X-ray absorptiometry and measurements of a series of biochemical indices were performed before and after medication at 24 and 48 weeks.
Results After medication, BMD increased in XLGB and Livial groups, especially in femur (Total).
In Livial group, the levels of E2 increased rapidly (P < 0.01),while levels of IL-6, TNF-a and NTX decreased ( P < 0.01).
In XLGB group, no changes in levels of E2 occurred , while levels of IGF-I increased ( P < 0.01) ;the other indices were the same as in Livial group. In Leli group and control group, BMD E2 , ALP, BGP and IGF-I decreased ( P < 0.05), while levels of IL-6,TNF-α and NTX increased (P<0.05).
Conclusion XLGB significantly improves BMD as Livial does. Thus it plays an important role in the treatment of osteoporosis.
But calcium tablet can not prevent the loss of bone.
Publications of researches on Xianling Gubao
1) J Bone Miner Res. 22:1072-1079, 2007
Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: a 24-month randomized, double-blind and placebo-controlled trial
- JBMR website: http://www.jbmronline.org/doi/abs/10.1359/jbmr.070405
2) Bone, 40 (3): 685-692, 2006
4) J Bone Miner Metab. 2005
Phytoestrogen-rich herb formula "XLGB" prevents OVX-induced deterioration of musculoskeletal tissues at the hip in old rats
4A) BONE 32 (5): S211-S21, 2003
Phytoestrogen-rich herbal formula XLGB in prevention of OVX induced bone loss in rats
5) Phytotherapy Research (in print), 2007
Dosing effects of an anti-osteoporosis herbal formula – A preclinical investigation using rat model.
6) Phytotherapy Research 21 (2): 99 - 112, 2006
Natural products as alternative treatments for metabolic bone disorders and for maintenance of bone health